Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Viapath restructures

Viapath, a clinical pathology company, has announced that it is to restructure into three separate branches: Viapath Group, Viapath Analytics and Viapath Services.

Viapath Group will set the firm’s business strategy while the analytics and services branches will deliver laboratory services and infrastructure management respectively.

Founded in 2009 as GSTS Pathology, the company was formed as a joint venture between Guy's & St. Thomas' NHS Foundation Trust and the outsourcing firm Serco.

Bedford Hospital and King’s College Hospital NHS Foundation Trust subsequently joined forces with GSTS and Serco in 2009 and 2010 respectively. In May 2014 the company rebranded from GSTS Pathology to Viapath.

In light of the restructuring, staff working for Viapath at Guy's & St Thomas' and Kings College Hospital will now work under Viapath directly.

Company chief executive Richard Jones (pictured) commented that this was an “important step” for Viapath because it would bring “all staff under one organisation”.


Related articles:

Posted on: 07/01/2015

Latest news stories

19/11/2018
Health Education England has appointed Sir David Behan as chair – effective from 1 December.
19/11/2018
NHS England has lifted the safety restrictions which limited the types of patients eligible to use GP at Hand services following a NHS clinical review.
16/11/2018
Care provider Regard Group has appointed Tracy Kite (pictured) as director of learning and leadership development.
15/11/2018
The McAvoy Group has been awarded a £15 million contract for the offsite construction of a new wing at Northumbria Specialist Emergency Care Hospital, Cramlington.
14/11/2018
Independent investment manager Albion Capital has invested £5 million in The Evewell, a fully-integrated medical centre specialising in reproductive and gynaecological health.


Civica


HealthInvestor blog
The Care Quality Commission is finding its voice as a regulator, but is anyone listening?

Click here to view the HealthInvestor blog


An interest in people rather than machines led to Andrew Lennox dedicating his career to improving patient outcomes
The Care Quality Commission’s latest summary of the state of health and social care points to an unfair and fragmented system
Echo co-founder Stephen Bourke tells Jack Carter how his app is simplifying the repeat prescription process
With the care village market still very much in its infancy in the UK, perhaps two of the biggest questions facing every care village developer, investor and operator are how much can we sell our care village apartments for, and will they hold their value? Carterwood director Ben Hartley provides some answers
Vet sector consolidation means the risk of CMA intervention is increasing, say Andrew Taylor and Nick Warren, partners at Aldwych Partners

Click here to search all feature articles



Deal in the spotlight

Elysium Healthcare's acquisition of LCP takes the group portfolio to more than 60 homes in just two years
Read more


Christie + Co

my images



Veterinary

Vet sector consolidation means the risk of CMA intervention is increasing, say Andrew Taylor and Nick Warren, partners at Aldwych Partners
Read more